Dr Reddys Profile

USD 0.41  1.38%

Dr Reddys Summary

Dr Reddys Laboratories Limited (RDY) is traded on BATS Exchange in USA. It is located in INDIA and employs 23,524 people. Dr Reddys is listed under Pharmaceutical Products category by Fama And French industry classification.The company currently falls under 'Mid-Cap' category with total capitalization of 5.68 B. Dr Reddys Laboratories Limited runs under Healthcare sector within Drug Manufacturers - Other industry. This company has 165.88 M outstanding shares of which 1.85 M shares are at this time shorted by investors with about 2.17 days to cover shorted positions. DR. REDDY'S LAB L has about 306.55 M in cash with 70.13 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.85.
Check Dr Reddys Probability Of Bankruptcy

Ownership Allocation (%)

Target Price Odds Analysis

Odds Below 29.25HorizonTargetOdds Above 29.25
2.76%30 days 29.25 97.21%
Based on normal probability distribution, the odds of Dr Reddys to move above current price in 30 days from now is about 97.0% (This Dr Reddys Laboratories Limited probability density function shows the probability of Dr Reddys Stock to fall within a particular range of prices over 30 days) .

Major Institutional Holders

InstituionSecurity TypeTotal SharesValue
Bank Of MontrealCommon Shares139.5 K4.5 M
Hexavest IncCommon Shares41.5 K1.3 M
View Dr Reddys Diagnostics

Dr Reddys Laboratories Risk Profiles

Key Fundamentals

Dr Reddys Against Markets

Risk Adjusted
Performance Score (0 to 100)
Chance of
Financial Distress (0 to 100%)
Equity ratings for Dr Reddys Laboratories Limited are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
Reddys Laboratories Limited operates as an integrated pharmaceutical company worldwide. Reddys Laboratories Limited was founded in 1984 and is headquartered in Hyderabad, India. Dr Reddys operates under Drug Manufacturers - Specialty Generic classification in USA and traded on New York Stock Exchange. It employs 23524 people. more
Fama & French Pharmaceutical Products
Pharmaceutical Products
Fama & French Classification
Dr Reddys Laboratories SEC Filings
Dr Reddys SEC Filings
Security & Exchange Commission EDGAR ReportsView All
NameDr Reddys Laboratories Limited
ChairmanG PrasadView All
Thematic Classifications
Active Investing Ideas
Analyst Consensus
Macroaxis Advice
Healthcare, Drug Manufacturers - Specialty & Generic
InstrumentUSA Stock View All
Business Address8-2-337, Road No. 3
ExchangeBATS Exchange
IndustryDrug Manufacturers - Other
Phone91 40 4900 2900
CurrencyUSD - US Dollar

Dr Reddys Corporate Directors

Hans Hasler Additional Independent Director
Ravi Bhoothalingam Non-Executive Independent Director
Prasad Menon Additional Independent Director
Additionally take a look at Your Equity Center. Please also try Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.